Plus Therapeutics (PSTV) FCF Margin Growth (3y) (2014 - 2026)
Plus Therapeutics (PSTV) FCF Margin Growth (3y) (2014 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
FCF Margin Growth (3y) (Qtr) |
| 1 |
Alterity Therapeutics |
788,338.31 Bn |
788,338.28 Bn |
- |
- |
| 2 |
Belite Bio |
56,560.00 Bn |
56,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,329.30 Bn |
17,329.30 Bn |
- |
- |
| 4 |
Legend Biotech |
3,341.00 Bn |
3,340.71 Bn |
242.10 Mn |
10,029.00 |
| 5 |
Akari Therapeutics |
1,727.91 Bn |
1,727.91 Bn |
- |
- |
| 6 |
Evaxion A |
1,536.68 Bn |
1,536.67 Bn |
- |
- |
| 7 |
Psyence Biomedical |
238.34 Bn |
238.33 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
113.42 Bn |
106.17 Bn |
2.59 Bn |
723.00 |
| 9 |
Abivax |
95.45 Bn |
95.45 Bn |
- |
- |
| 10 |
Plus Therapeutics |
34.26 Mn |
19.15 Mn |
- |
49,162.00 |
| Date | Value |
|---|
| Mar 31, 2026 |
49,162.00 |
| Dec 31, 2025 |
139,861.00 |
| Sep 30, 2025 |
564,573.00 |
| Mar 31, 2019 |
-8,138.00 |
| Dec 31, 2018 |
11,961.00 |
| Sep 30, 2018 |
49,572.00 |
| Jun 30, 2018 |
-10,206.00 |
| Mar 31, 2018 |
766.00 |
| Dec 31, 2017 |
-44,210.00 |
| Sep 30, 2017 |
55,513.00 |
| Jun 30, 2017 |
47,236.00 |
| Mar 31, 2017 |
7,949.00 |
| Dec 31, 2016 |
6,951.00 |
| Sep 30, 2016 |
-13,044.00 |
| Jun 30, 2016 |
6,585.00 |
| Mar 31, 2016 |
28,887.00 |
| Dec 31, 2015 |
-8,209.00 |
| Sep 30, 2015 |
-19,285.00 |
| Jun 30, 2015 |
11,409.00 |
| Mar 31, 2015 |
-384.00 |
